Ozempic and Wegovy work. That is no longer discussed. Long-term studies, medical insurance data, and records of clinical records in the U.S.—such as those of Epic COSMOS covering 300 million patients—show real weight losses and reductions in cardiovascular risk factors. What is still being understood is the secondary price that some patients pay for that weight loss: muscle mass.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Ozempic and Wegovy work. That is no longer discussed. Long-term studies, medical insurance data, and records of clinical records in the U.S.—such as those of Epic COSMOS covering 300 million patients—show real weight losses and reductions in cardiovascular risk factors. What is still being understood is the secondary price that some patients pay for that weight loss: muscle mass.